KMDA — KAMADA LTD

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1567529 ·
Last close
$8.16
Market Cap
$470.92M
52W High
$8.96
52W Low
$6.28
ADV30
100,642
Next earnings
2026-11-09

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 52,034,000 23,335,000 10,371,000 7,990,000 382,716,000 75,317,000 114,348,000
Jun 2026 54,921,000 22,467,000 9,510,000 9,262,000 383,162,000 29,473,000 113,604,000
Mar 2026 45,240,000 19,116,000 6,953,000 4,132,000 383,021,000 32,922,000 123,634,000
Dec 2025 44,678,000 16,967,000 3,551,000 3,562,000 378,710,000 75,469,000 109,640,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$35,759,000
Investing CF
$-50,104,000
Financing CF
$-21,785,000
CapEx
$-9,444,000
Dividends Paid
$-14,421,000
Buybacks
—
EPS Diluted TTM
$0.38
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-18,101,000
Inventory
$86,875,000
Receivables
$42,566,000
ST Investments
$40,660,000
EBIT TTM
$27,720,000
Pretax Income TTM
$26,681,000
Interest Exp TTM
$1,039,000
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$191,848,992
EBITDA
$41,494,000
Free Cash Flow
$15,506,375
Enterprise Value
$400,136,992
Total Cash
$70,133,000
Total Debt
$11,801,000
Shares Out
57,710,305
Trailing EPS
$0.38
Book Value
$4.66
ROE
8.4%
ROA
4.6%
Div Yield
2.14%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 180,460,000 26,233,000 20,198,000 378,710,000 109,640,000 269,070,000 25,490,000
Dec 2024 160,953,000 20,051,000 14,462,000 372,255,000 112,791,000 259,464,000 47,594,000
Dec 2023 142,519,000 10,064,000 8,284,000 354,907,000 110,886,000 244,021,000 4,315,000
Dec 2022 129,339,000 4,532,000 -2,321,000 322,379,000 146,359,000 176,020,000 28,586,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.60

Max Pain — expiry 2027-05-21 (volume-derived — Yahoo OI feed degraded)

max pain strike: $7.50 · spot: $8.07 · call volume: 0 · put volume: 15
Expected Move to 2027-05-21: ±$3.30 (40.89%) — implied range $4.77 – $11.37 · ATM straddle on $7.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
AMRN AMARIN CORP PLC\UK $473.82M $11.27 —
STTK Shattuck Labs, Inc. $467.46M $4.59 —
AQST Aquestive Therapeutics, Inc. $465.04M $3.70 —
NGNE Neurogene Inc. $478.19M $23.10 —
IMMP IMMUTEP Ltd $480.43M $3.26 —

News headlines (Yahoo Finance, 1h cache)

Kamada Ltd (KMDA) (Q3 2026) Earnings Call Highlights: Record Nine-Month Revenue and Raised ...
2026-11-09 21:06 · Yahoo
Kamada Ltd. Q3 2026 Earnings Call Summary
2026-11-09 17:52 · Yahoo
Kamada (KMDA) Q3 2026 Earnings Call Transcript
2026-11-09 17:13 · Yahoo
Kamada Q3 Earnings Call Highlights
2026-11-09 15:14 · Yahoo
Kamada (KMDA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
2026-11-09 13:30 · Yahoo
Kamada (KMDA) Surpasses Q3 Earnings Estimates
2026-11-09 12:25 · Yahoo
Kamada: Q3 Earnings Snapshot
2026-11-09 12:17 · Yahoo
Kamada Reports Record-High First Nine Months 2026 Financial Results; Increases 2026 Annual Guidance and Projects Double-Digit Growth in Revenues and Profitability in 2027
2026-11-09 12:02 · Yahoo
Kamada Declares Cash Dividend of $0.14 Per Share; The Company Continues its Record-High Year
2026-11-09 12:00 · Yahoo
Ahead of Kamada (KMDA) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
2026-11-05 13:15 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.